Hemochromatosis: Important Scientific articles and information

Free PDF reader | Medline: H(A)EMOCHROMATOSIS | Omim (hemochromatosis) | Newsarticles on Google
European Iron Club for professionals in Biomedical Inorganic Iron | World congress on Iron Metabolism 2009
Protocols: Dutch protocol 2007 | Canada, Dec. 2006 | British Society for Haematology, Feb 2000 | French (english) protocol 2005  | Translation of French protocol treatment)

For patiënts: The protocols above give a good overview! Articles below possibly give a misleading impression if read on their own!
ALWAYS CONSULT YOUR DOCTOR!


2008, May: Environmental and genetic modifiers of the progression to fibrosis and cirrhosis in hemochromatosis
2008, May: Assessment of the psychological effects of genetic screening for hereditary hemochromatosis
2008, May: The biochemical and clinical penetrance of individuals diagnosed with genetic haemochromatosis by predictive genetic testing
2008; May: HFE Mutations in Nonalcoholic Fatty Liver Disease
2008, Winter: Survival advantage of the hemochromatosis C282Y mutation
2008, Apr: Serum ferritin concentrations and body iron stores in a multicenter, multiethnic primary-care population.
2008, Apr: Screening for hemochromatosis by measuring ferritin levels: a more effective approach (see also 2 comments below)
2008, Apr: Ferritin >1000: grand for hemochromatosis screening?
2008, Apr: Screening for hemochromatosis
2008, Apr: Current approach to hemochromatosis
2008, Mar: Environmental and genetic modifiers of the progression to fibrosis and cirrhosis in hemochromatosis
2008, Mar: Doctors subscribe to high dosages of iron supplements in iron deficiency anemia
2008, Mar: Hemochromatosis and and medicines (containing iron)
2008, Mar: Bloodletting ameliorates insulin sensitivity (...): response to Equitani et al.
2008, Mar: Bloodletting Ameliorates Insulin Sensitivity (...): Response to Valenti et al
2008, Feb: Family-based Detection for Hereditary Hemochromatosis
2008, Feb: Characteristics of participants with self-reported hemochromatosis or iron overload at HEIRS study initial screening
2008, Feb: All patients with 'idiopathic' hypopituitarism should be screened for hemochromatosis
2008, Jan: The Hand Arthropathy of Hereditary Hemochromatosis Is Strongly Associated with Iron Overload
2008, Jan: Tauroursodeoxycholic acid: Relieving the pathogenesis of HFE C282Y hereditary
2008, Jan: Iron and the liver: Update 2008
2008, Jan: Bloodletting ameliorates insulin sensitivity and secretion in parallel to reducing liver iron in carriers of HFE gene mutations
2008, Jan: Editorial: Clinical penetrance of hereditary hemochromatosis
2008, Jan: Iron-overload-related disease in HFE hereditary hemochromatosis
2007, Dec: Synopsis of the Dutch multidisciplinary guideline for the diagnosis and treatment of hereditary haemochromatosis
2007, Dec: Morbidity and mortality in first-degree relatives of C282Y homozygous probands with clinically detected haemochromatosis compared with the general population: the HEmochromatosis FAmily Study (HEFAS)
2007, Dec: Changing aspects of HFE-related hereditary haemochromatosis and endeavours to early diagnosis 
2007, Dec: Hereditary Hemochromatosis, editorial (related to the above articles NJM)
2007, Dec: Haemochromatosis (review Adams and Barton)
2007, Nov: Biological variability of transferrin saturation and unsaturated iron-binding capacity.
2007, Nov: Iron, hepatitis C virus, and hepatocellular carcinoma: iron reduction preaches the gospel for chronic hepatitis C
2007, Nov: Results communication and patient education after screening for possible hemochromatosis and iron overload: experience from the HEIRS Study of a large ethnically and linguistically diverse group
2007, Okt: Proton pump inhibitors suppress absorption of dietary non-haem iron in hereditary haemochromatosis
2007, Okt: The arthropathy of haemochromatosisnext term and the role of the orthopaedic surgeon
2007, Okt: Genetic screening for iron overload: No evidence of discrimination at 1 year
2007, Fall: HFE C282Y homozygotes aged 25-29 years at HEIRS Study initial screening


2007, Okt: Clinical Expression of Hemochromatosis Gene (HFE) Variants
2007, Okt: Hemochromatosis: An Endocrine Liver Disease
2007, Okt: Hemochromatosis Genotypes and Risk of 31 Disease Endpoints: Meta-Analyses Including 66,000 Cases and 226,000 Controls
2007, Okt: HH screening: effect of mutation penetrance and prevalence on cost-effectiveness of testing algorithms
2007, Okt: Common variants in the BMP2, BMP4, and HJV genes of the hepcidin regulation pathway modulate HFE hemochromatosis penetrance
2007, Sep: Directions for clinical practice improvement in HFE gene mutation testing
2007, Sep: Long-term phlebotomy with low-iron diet therapy lowers risk of development of hepatocellular carcinoma from chronic hepatitis C
2007, Sep: HFE gene in primary and secondary hepatic iron overload
2007, Sep: Non-HFE haemochromatosis
2007, Sep: Iron overload and cofactors
2007, Sep: Iron overload and immunity
2007, Sep: Molecular mechanisms involved in intestinal iron absorption
2007, Sep: Liver iron transport
2007, Sep: Role of iron in hepatic fibrosis: One piece in the puzzle
2007, Sep: Pathology of hepatic iron overload
2007, Aug: Heart failure and malignant ventricular tachyarrhythmias due to HH with iron overload cardiomyopathy
2007, Jul: Ferritin and Transferrin Are Associated With Metabolic Syndrome Abnormalities and Their Change Over Time in a General Population
2007, Jun: Chronic Daily Headache in HH Treated by Venesection
2007, Jun: MCV and Hb concentration in white HFE C282Y homozygotes in HEIRS
2007, Jun: Therapeutic erythrocytapheresis versus phlebotomy in the initial treatment of hereditary hemochromatosis - A pilot study
2007, May: Iron storage disease: Facts, fiction and progress
2007, May: Heart Rate Recovery is Lower Following Supine Exercise in Asymptomatic Hereditary Hemochromatosis Subjects Compared With Healthy Controls
2007, Apr: Mass spectrometry-based hepcidin measurements in serum and urine: analytical aspects and clinical implications
2007, Apr: Reversal of liver cirrhosis: a desirable clinical outcome and its pathogenic background
2007, Apr: Ca2+ channel blockers reverse iron overload by a new mechanism via divalent metaltransporter-1
2007, Apr: HFE Gene Mutation, Chronic Liver Disease, and Iron Overload In Turkey
2007, Mar: Body iron is acontributor to oxidative damage of DNA
2007, Mar: Iron overload in the liver diagnostic and quantification
2007, Mar: Low plasma volume and absent feeling of thirst – a special syndrome with a link to haemochromatosis
2007, Mar: Body iron is a contributor to oxidative damage of DNA
2007, Feb: The H63D mutation in the HFE gene predisposes to arthralgia, chondrocalcinosis, and osteoarthritis
2007, Feb: The Iron-Heart Hypothesis: Search for the Ironclad Evidence
2007, Jan: Heme Iron From Diet as a Risk Factor for Coronary Heart Disease in Women With Type2 Diabetes
2007, ???: Optimal Management Strategies for Chronic Iron Overload
2007, ???: Iron Depletion by Phlebotomy Improves Insulin Resistance in Patients With Nonalcoholic Fatty Liver Disease and Hyperferritinemia
2007, ???: Protective role of calreticulin in HFE hemochromatosis
2007, ???: HFE variants, APOE and Alzheimer’s disease
2007, ???: Characteristics of participants with self-reported hemochromatosis or ironoverload at HEIRS Study initial screening
2007, ???: HH should be considered a conformational disorder
2007, ???: Association of hemochromatosis with infectious diseases: expanding spectrum
2007, ???: Bloodletting: Past and present
2007, ???: Elevated serum ferritin levels predict new-onset type2 diabetes
2007, ???: Cardiac Hemochromatosis
2007, ???: Oxidative stress-induced risk factors associated with the metabolic syndrome
2007, ???: Oxidative stress, and iron and antioxidant status in elderly men
2007, ???: Iron overload and clinical characteristics in a Spanish cohort of 100 C282Y patients
2007, ???: African Americans at Risk for Increased Iron Stores or Liver Disease
2007, ???: HH genotypes and risk of ischemic stroke
2007, ???: Penetrance of the C28Y/C282Y genotype of the HFEgene
2007, ???: HH: Changes in the last three decades in Italy
2007, ???: Reversal of cardiac complications by deferiprone and deferoxamine in juvenile hemochromatosis case (JH)
2007, ???: Exercise Capacity of Cardiac Asymptomatic Hereditary Hemochromatosis Subjects
2007, ???: Hemochromatosis: A Neolithic adaptation to cereal grain diets
2007, ???: Survival of Liver Transplant Recipients With Hemochromatosis in the United States
2007, ???: Psychosocial Impact of Genetic Testing for Hemochromatosisin the HEIRS Study
2007, ???: Iron overload in the liver diagnostic and quantification
2006, Dec: Increased expression of hepcidin in obese patients: impact on phenotypic expression of hemochromatosis
2006, Nov: The Clinical Relevance of Compound Heterozygosity for the C282Y and H63D Substitutions in Hemochromatosis
2006, Nov: Best practice guidelines for the molecular genetic diagnosis of Type1 (HFE-related) hereditary haemochromatosis
2006, Nov: Increased insulin secretory capacity but decreased insulin sensitivity after correction of iron overload by phlebotomy in hereditary haemochromatosis
2006, Okt: Iron overload and prolonged ingestion of iron supplements: clinical features and mutation analysis of hemochromatosis-associated genes in four cases
2006, Okt: Circulating gastrin is increased in hemochromatosis
2006, Sep: Relationships of Serum Ferritin, Transferrin Saturation, and HFE Mutations and Self-Reported Diabetes
2006, Sep: Sporadic porphyria cutanea tarda due to haemochromatosis
2006, Sep: Juvenile hemochromatosis
2006, Sep: Oxidative Stress in Asymptomatic Subjects With Hereditary Hemochromatosis
2006, Aug: Reversibility of Hepatic Fibrosis in Treated Genetic Hemochromatosis: A Study of 36 Cases
2006, Aug: Screening for Hereditary Hemochromatosis: A Systematic Review for the U.S. Preventive Services Task Force
2006, Aug: Screening for Hemochromatosis: Recommendation Statement
2006, Aug: Oxidative Stress in Asymptomatic Subjects With HH
2006, Jul: Surgery for Hepatocellular Carcinoma Arising in HH
2006, Jul: Liver diseases in the hemochromatosis and iron overload screening study
2006, Jun: Government document Ireland: The nature and extent of Haemochromatosis in Ireland
2006, Jun: Primary Osteoarthritis in the Ankle Joint Is Associated With Finger Metacarpophalangeal Osteoarthritis and the H63D Mutation
2006, Jun: Iron Intake and the Risk of Type2 Diabetes in Women
2006, May: Hereditary hemochromatosis: Review: Antonello Pietrangelo
2006, May: Hereditary Hemochromatosis: Genetic Complexity and New Diagnostic Approaches
2006, May: Revisiting hereditary hemochromatosis: current concepts and progress
2006, May: Using skin to assess iron accumulation in human metabolic disorders
2006, May: Common Presence of Non–Transferrin-Bound Iron Among Patients With Type2 Diabetes
2006, Apr: Individuals Homozygous for the H63D Mutation Have Significantly Elevated Iron Indexes
2006, Apr: Fetal and Infantile Hemochromatosis
2006, Apr: Iron loading and morbidity among relatives of HFE C282Y homozygotes identified either by population genetic testing or presenting as patients
2006, Apr: The effect of the metabolic syndrome, hepatic steatosis and steatohepatitis on liver fibrosis in hereditary hemochromatosis
2006, Mar: Population-based study of the relationship between mutations in the hemochromatosis (HFE) gene and arthritis
2006, Feb: HH in 3,500 Patients With Diabetes
2006, Feb: Evaluation of a Diagnostic Algorithm for Hereditary Hemochromatosis in 3,500 Patients With Diabetes
2006, Feb: Screening for hemochromatosis in asymptomatic subjects with or without a family history
2006, ???: Current approaches to the management of hemochromatosis
2006, ???: Iron Overload and Prolonged Ingestion of Iron Supplements
2006, ???: Impact of hemochromatosis screening in patients with indeterminate results
2006, ???: Revisiting HH: Current Concepts and Progress
2006, ???: Fear of needles and vasovagal reactions among phlebotomy patients
2006, ???: Predictors of Belief That Genetic Test Information About Hemochromatosis Should Be Shared with Family Members
2006, ???: Genetic predisposition to iron overload: Prevalence and phenotypic expression of hemochromatosis-associated HFE-C282Y gene mutation
2006, ???: Clinical expression of C282Y homozygous HFE haemochromatosis at 14 years of age
2006, ???: Early diagnosis of hemochromatosis-related cardiomyopathy with MRI
2005, Dec: HFE Genetic Variability, Body Iron Stores, and the Risk of Type 2 Diabetes in U.S. Women
2005, Dec: Steatosis Is a Cofactor in Liver Injury in Hemochromatosis
2005, Okt: Phenotype variation in C282Y homozygotes for the hemochromatosis gene
2005, Okt: Screening for hereditary hemochromatosis: a clinical practice guideline from the American College of Physicians
2005, Okt: Screening primary care patients for hereditary hemochromatosis with transferrin saturation and serum ferritin level: review
2005, Sep: Attitudes Toward Genetic Testing and Psychosocial Impact: HH— German Pilot Study
2005, Sep: A computer-assisted morphometric quantitative analysis of iron overload in liver biopsies
2005, Sep: Iron loading and morbidity among relatives of HFE C282Y homozygotes identified either by population genetic testing or presenting as patients
2005, Jul: Liver iron concentration evaluated by two magnetic methods: magnetic resonance imaging and magnetic susceptometry.
2005, Jun: Restless legs syndrome in patients with hereditary hemochromatosis (PAGE 8)
2005, Jun: Impact of HFE genetic testing on clinical presentation of HH
2005, Jun: Role of early case detection by screening relatives of patients with HFE-associated hereditary haemochromatosis
2005, Jun: Redox active plasma iron in C282Y/C282Y hemochromatosis
2005, Jun: Hepcidin--a regulator of intestinal iron absorption and iron recycling by macrophages
2005, Jun: Genetic nondiscrimination
2005, May: The evaluation of hyperferritinemia: an updated strategy based on advances in detecting genetic abnormalities.
2005, May: Reverse cascade screening of newborns for hereditary haemochromatosis: a model for other late onset diseases?
2005, May: Disease-related conditions in relatives of patients with hemochromatosis
2005, Apr: Duration of hepatic iron exposure increases the risk of significant fibrosis in hereditary hemochromatosis: a new role for magnetic resonance imaging.
2005, Apr: A Case of Fatal Hemochromatosis in a 33-Year-Old Woman
2005, Mar: Transferrin Saturation, Dietary Iron Intake, and Risk of Cancer
2005, Mar: Soluble transferrin receptor in hemochromatosis patients during phlebotomy therapy
2005, Feb: Demanding pure motives for donation: the moral acceptability of blood donations by haemochromatosis patients
2005, Jan: Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance
2005, Jan: Management of Hemochromatosis in a Jehovah’s Witness
2005, ???: Prevalence of Body Iron Excess in the Metabolic Syndrome
2005, ???: Prevalence of HFE Gene Mutations in Patients With Cluster Headache
2005, ???: Erythrocytapheresis plus erythropoietin
2005, ???: Non-invasive assessment of hepatic iron overload: are we finally there?
2005, ???: Role of early case detection by screening relatives of patients with HFE-associated hereditary haemochromatosis
2004, Dec: Hepatic iron loading in patients with compound heterozygous HFE mutations
2004, Okt: Genotype-based screening for hereditary haemochromatosis. I: Technical performance, costs and clinical relevance of a German pilot study
2004, Okt: Serum ferritin and risk of the metabolic syndrome in U.S. adults
2004, Sep: The recently identified type 2A juvenile haemochromatosis gene (HJV), a second candidate modifier of the C282Y homozygous phenotype
2004, Sep: The origin and spread of the HFE-C282Y haemochromatosis mutation
2004, Sep: No Hepatic Iron Overload 12 Years After Liver Transplantation for HH
2004, Aug: Does bilirubin protect against hemochromatosis gene (HFE) related mortality?
2004, Jun: Review: A new look at an old disease
2004, Jun: HH Genetic Testing of At-Risk Children: What Is the Appropriate Age?
2004, Jun: HH: A new look at an old disease
2004, Jun: Histological Resolution of Steato hepatitis After Iron Depletion
2004, May: Changing the clinical management of hereditary hemochromatosis
2004, Apr: From families to genes and back: can a hemochromatosis gene help. treat the anemia of chronic disease?
2004, Apr: Hemochromatosis mutations in the general population: iron overload progression rate
2004, Mar: Elevated serum T.S.% and mortality
2004, Mar: Mortality risk of elevated T.S.% and consumption of dietary iron
2004, Feb: Body Iron Stores in relation to risk of diabetes
2004, Feb: MR quantification of hepatic iron concentration
2004, Feb: The Use of EMLA Cream to Decrease Venipuncture Pain in Children
2004, Feb: Body Iron Stores in Relation to Risk of Type 2 Diabetes in Apparently Healthy Women
2004, Feb: The use of Emla creme to decrease venepuncture pain in children
2004, Feb: Arthritis in hemochromatosis
2004, Jan: High prevalence of non-HFE gene-associated haemochromatosis in patients from southern Italy
2004, Jan: Non-invasive assessment of hepatic iron stores by MRI
2004, ???: Learn how to “bleed” a patient whose iron stores are dangerously high
2004, ???: Evolution of untreated HH: a 17 year study
2004, ???: IRON OUT THE DETAILS OF THERAPEUTIC PHLEBOTOMY
2004, ???: Quality-related variables at hepatological websites
2004, ???: Animals and iron overload
2004, ???: HH without organ damage: a rescue resource for blood supply?
2003, Dec: Phlebotomy-Mobilized Iron as a Surrogate for Liver Iron Content in Hemochromatosis Patients
2003, Dec: Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization
2003, Dec: Effective treatment of hereditary haemochromatosis with desferrioxamine in selected cases
2003, Dec: Identification of new mutations of the HFE, hepcidin, and transferrin receptor 2 genes by HPLC analysis
2003, Dec: Cancer risk in patients with hereditary hemochromatosis and in their first-degree relatives
2003, Dec: Screening for hereditary haemochromatosis within families and beyond
2003, Nov: Hemochromatosis subjects as allogeneic blood donors
2003, Nov: Iron overload and its association with cancer risk
2003, Sep: A European allele map of the C282Y mutation of hemochromatosis: Celtic versus Viking origin of the mutation?
2003, Sep: Patient compliance with phlebotomy therapy for HH
2003, Sep: Results of liver transplantation according to indications for orthotopic liver transplantation
2003, Aug: Effect of alcohol on iron storage diseases of the liver
2003, Jul: Prevalence and Penetrance of HFE Mutations in 4865 Unselected Primary Care Patients
2003, Jul: Cys282Tyr originated from Southern Scandinavia and spread with the Vikings
2003, Jul: Hereditary Hemochromatosis: Effect of Excessive Alcohol Consumption on Disease Expression
2003, Jun: Hemochromatosis and alcoholic liver disease
2003, Jun: Iron-induced oxidant stress in alcoholic liver fibrogenesis
2003, May: Natural History of the Non-expressing C282Y Homozygote for the Hemochromatosis Gene (HFE)
2003, May: Clinical consequences of iron overload in hemochromatosis homozygotes
2003, May: The HFE Cys282Tyr mutation as a necessary but not sufficient cause of clinical hereditary hemochromatosis
2003, May: Insurance, employment, and psychosocial consequences of a diagnosis of hereditary hemochromatosis in subjects without end organ damage
2003, Apr: Penetrance of haemochromatosis
2003, Apr: Cys282Tyr: Celtic versus Viking origin of the mutation?
2003, Apr: Constitutive hepcidin expression prevents iron overload in a mouse model of hemochromatosis
2003, Apr: Serum ferritin level predicts advanced hepatic fibrosis among U.S. patients with phenotypic hemochromatosis 2003, Feb: A targeted approach significantly increases the identification rate of patients with undiagnosed haemochromatosis
2003, Feb: Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis
2003, Feb: Health Implications of Iron Overload: The Role of Diet and Genotype
2003, Jan: Circadian variations of transferrin saturation levels in iron-overloaded patients: implications for the screening of C282Y-linked haemochromatosis
2003, ???: Serum Ferritin Level Predicts Advanced Hepatic Fibrosis among U.S. Patients with Phenotypic Hemochromatosis
2003, ???: Compassion for First-Time Phlebotomy Patients
2003, ???: Clinical consequences of iron overload in hemochromatosis homozygotes
2003, ???: Platelet Count Increase Following Phlebotomy in Iron Overloaded Patients with Liver Cirrhosis
2002, Dec: Young female with HH
2002, Nov: Non-Invasive Liver Iron Quantification by SQUID-Biosusceptometry ans SF in HH
2002, Nov: The role of hemochromatosis C282Y and H63D gene mutations in type 2 diabetes: findings from the Rotterdam Study and meta-analysis
2002, Nov: Seeking Candidate Mutations That Affect Iron Homeostasis
2002, Okt: Iron toxicity and antioxidant nutrients
2002, Sep: Radial artery wall alterations in genetic hemochromatosis before and after iron depletion therapy
2002, Sep: Noninvasive Prediction of Cirrhosis in C282Y-Linked Hemochromatosis
2002, Sep: Concordance of iron indices in homozygote and heterozygote sibling pairs in hemochromatosis families: implications for family screening
2002, Aug: Genetic testing for haemochromatosis in patients with chondrocalcinosis
2002, Aug: Should we screen for hemochromatosis? An examination of evidence of downstream effects on morbidity and mortality
2002, Aug: Unsaturated iron binding capacity and transferrin saturation are equally reliable
2002, Aug: Increased serum ferritin is common in men with essential hypertension
2002, Jul: Underdiagnosis of hereditary haemochromatosis: lack of presentation or penetration?
2002, Jun: Persons with screening-detected haemochromatosis: as healthy as the general population?
2002, Jun: High headache prevalence among women with hemochromatosis: the Nord-Trondelag health study
2002, May: Family screening: iron indices in homozygote and heterozygote sibling pairs
2002, Mar: Diabetes and HFE mutations: cause or coincidence?
2002, Mar: Should all patients with diabetes mellitus be screened for hemochromatosis?
2002, Mar: Apheresis removes excess iron twice as fast as manual whole blood phlebotomy
2002, Mar: A population-based study of the biochemical and clinical expression of the H63D hemochromatosis mutation
2002, Mar: Testing for haemochromatosis in a liver clinic population
2002, Feb: HH in two cousins with cluster headache
2002, Feb: Red cell apheresis removes excess iron twice as fast as manual whole blood phlebotomy
2002, Feb: Excess Alcohol Greatly Increases the Prevalence of Cirrhosis in HH
2002, Feb: Hereditary hemochromatosis and alcohol: a fibrogenic cocktail
2002, Jan: Penetrance of 845G--> A (C282Y) HFE hereditary haemochromatosis mutation in the USA
2002, Jan: Hereditary hemochromatosis of a young girl: detection of early iron deposition in liver cell lysosomes
2002, ???: Haemochromatosis arthropathy and repetitive trauma
2002, ???: Blood Letting in High-Ferritin Type2 Diabetes
2002, ???: Genetic testing for haemochromatosis in patients with chondrocalcinosis
2002, ???: HH a realistic approach to prevention in the population
2002, ???: Mild iron overload in patients carrying the HFE S65C
2001, Dec: The importance of non-transferrin bound iron in disorders of iron metabolism
2001, Dec: Clinically overt hereditary hemochromatosis in Denmark 1948–1985
2001, Nov: Disease-Related Conditions in Relatives of Patients with Hemochromatosis.
2001, Okt: Prevalence of hereditary haemochromatosis in late-onset type 1 diabetes mellitus: a retrospective study
2001, Okt: Screening for hemochromatosis: high prevalence and low morbidity in an unselected population of 65,238 persons
2001, Okt: Reference centiles for serum ferritin and percentage of transferrin saturation, with application to mutations of the HFE gene
2001, Okt: Hemochromatosis: the irony of population screening
2001, Sep: Hemochromatosis at the intersection of classical medicine and molecular biology: review
2001, Okt: Prevalence of hereditary haemochromatosis in late-onset type 1 diabetes mellitus: a retrospective study
2001, Sep: Prevalence, donation practices, and risk assessment of blood donors with hemochromatosis
2001, Sep: Venesection therapy of insulin resistance-associated hepatic iron overload
2001, Sep: A Rare Case of a Patient Heterozygous for the Hemochromatosis Mutation C282Y and Homozygous for H63D
2001, Aug: Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis
2001, Aug: HFE mutations, iron deficiency and overload in 10,500 blood donors
2001, Aug: HFE Gene and Hereditary Hemochromatosis: A HuGE Review
2001, Aug: Liver transplantation for hereditary hemochromatosis
2001, Jul: Iron metabolism, free radicals, and oxidative injury
2001, Jul: Hemochromatosis mutations C282Y and H63D in 'cis' phase
2001, Jul: Role of hemochromatosis mutations in development of type 2 diabetes
2001, Jul: Reduced serum ceruloplasmin levels in hereditary haemochromatosis
2001, Jun: MCV as a guide to phlebotomy therapy for hemochromatosis
2001, Jun: Variable phenotypic presentation of iron overload in H63D homozygotes: are genetic modifiers the cause?
2001, Jun: Estimating the Efficacy and Efficiency of Cascade Genetic Screening
2001, May: Diagnosis and management of hemochromatosis
2001, Mar: Histological evaluation of iron in liver biopsies: relationship to HFE mutations
2001, Mar: Total iron-binding capacity and serum transferrin determination under the influence of several clinical conditions
2001, Apr: Phlebotomy, Blood Donation, and Hereditary Hemochromatosis
2001, Feb: Is there a threshold of hepatic iron concentration that leads to cirrhosis in C282Y hemochromatosis?
2001, Feb: Liver Biopsy
2001, Feb: Effect of hemochromatosis genotype and lifestyle factors on iron and red cell indices in a community population
2001, Jan: Preserving the National Blood Supply (focus on iron and hemochromatosis)
2001, Jan: Severity of iron overload in hemochromatosis: effect of volunteer blood donation before diagnosis
2001, Jan: The pituitary gland and hereditary hemochromatosis
2001, Jan: Arthropathy in hereditary hemochromatosis
2001, ???: Cardiac Transplantation in a Patient with Hereditary Hemochromatosis: Role of Adjunctive Phlebotomy and Erythropoietin
2000, Dec: Biochemical expression of heterozygous hereditary hemochromatosis
2000, Dec: Liver transplantation in patients with hepatic iron overload: Favorable or unfavorable outcome?
2000, Dec: Why there is discordance in reported decision thresholds for transferrin saturation when screening for hereditary hemochromatosis
2000, Nov: Unsaturated iron-binding capacity: a screening test for C282Y hemochromatosis?
2000, Okt: Contribution of different HFE genotypes to iron overload disease: a pooled analysis
2000, Sep: EASL International Consensus Conference on Haemochromatosis
2000, Sep: Radial artery wall alterations in genetic hemochromatosis before and after iron depletion therapy
2000, Aug: Hepatocellular Carcinoma Occurring in Nonfibrotic Liver
2000, Jul: Iron Reduction as an Adjuvant to Interferon Therapy in Patients With Chronic Hepatitis C
2000, May: Population screening for HH: Editorial
2000, May: Population screening for HH: a comparison of unbound iron-binding capacity, transferrin saturation, and C282Y genotyping in 5,211 voluntary blood donors.
2000, May: Screening for genetic haemochromatosis in blood samples with raised alanine aminotransferase xxx Reply
2000, Mar: Iron Reduction Before and During Interferon Therapy of Chronic Hepatitis C: Results of a Multicenter, Randomized, Controlled Trial
2000, Mar: Hemochromatosis genes and other factors contributing to the pathogenesis of porphyria cutanea tarda
2000, Apr: Quantification of liver iron concentration with magnetic resonance imaging
2000, Feb: Compound heterozygous hemochromatosis genotype predicts increased iron and erythrocyte indices in women
2000, Feb: Screening for Hereditary Hemochromatosis in Siblings and Children of Affected Patients
2000, Jan: Diagnosis and management of haemochromatosis since the discovery of the HFE gene: a European experience
2000, Jan: Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion
2000, ???: EASL International Consensus Conference on Haemochromatosis
2000, ???: Renal transplantation and evolution of hemochromatosis: a clinical case report
2000, ???: Cardiac abnormalities in hemochromatosis
2000, ???: Iron Deficiency Due to Excessive Therapeutic Phlebotomy in Hemochromatosis
2000, ???: Genetic Discrimination and Screening for Hemochromatosis: Then and Now
1999, Okt: Commentary on HFE S65C Variant Is Not Associated with increased transferrin saturation
1999, Okt: HFE S65C variant is not associated with increased transferrin saturation in voluntary blood donors
1999, Sep: Heterozygosity for a hereditary hemochromatosis gene is associated with cardiovascular death in women: 1999 Sep
1999, Sep: Hyperferritinaemia in the absence of iron overload
1999, Sep: Hemochromatosis and vitamin C
1999, Sep: A population-based study of the clinical expression of the hemochromatosis gene
1999, Jun: A survey of phlebotomy among persons with hemochromatosis
1999, Feb: A Survey of 2,851 Patients with Hemochromatosis: Symptoms and Response to Treatment
1999, Feb: Phenotypic expression of HFE mutations: a French study of 1110 unrelated iron-overloaded patients and relatives
1999, Jul: Elevated serum type IV collagen: a sensitive indicator of the presence of cirrhosis in haemochromatosis
1999, Jul: Hepatic iron concentration: noninvasive estimation by means of MR imaging techniques
1999, Feb: Haemochromatosis and exercise related joint pains
1999, Jan: Molecular Medicine and Hemochromatosis: At the Crossroads
1999, ???: Ankle arthropathy in hemochromatosis (page9-10)
1999, ???: Heterozygosity for a HH Gene Is Associated With Cardiovascular Death in Women
1998, Dec: Screening for hemochromatosis in primary care settings
1998, Dec: Prevalence of hereditary hemochromatosis in 16031 primary care patients
1998, Oct: Hemochromatosis and male infertility
1998, Oct: Noninvasive prediction of fibrosis in C282Y homozygous hemochromatosis
1998, Aug: Clinical characteristics of hereditary hemochromatosis patients who lack the C282Y mutation
1998, Jul: Blokking iron absorbtion by drinking tea!
1998, Jun: C282Y mutation in HFE (haemochromatosis) gene and type 2 diabetes
1998, May: Factors affecting the rate of iron mobilization during venesection therapy for genetic hemochromatosis
1999, Apr: HFE mutations analysis in 711 hemochromatosis probands: evidence for S65C implication
1998, Mar: Distribution of transferrin saturation in an Australian population: relevance to the early diagnosis of hemochromatosis
1998, Mar: Hepatic iron concentration in hereditary hemochromatosis does not saturate or accurately predict phlebotomy requirements
1998, Mar: Prevalence of genetic hemochromatosis in a cohort of Italian patients with diabetes mellitus
1998, Mar: Haemochromatosis as an endocrine cause of subfertility
1998, Feb: Clinical and pathologic findings in hemochromatosis hip arthropathy
1998, Jan: Effects of therapeutic phlebotomies on genetic hemochromatosis regarding a French national epidemiologic study on a sample of 498 patients
1997, Dec: The relation between chemically measured total iron-binding capacity concentrations and immunologically measured transferrin concentrations in human serum 1997, Nov: The effect of withdrawal of food iron fortification in Sweden as studied with phlebotomy in subjects with genetic hemochromatosis
1997, Aug: PDF: Mild liver enzyme abnormalities: eliminating hemochromatosis as cause
1997, Jul: Clinical features of genetic hemochromatosis in women compared with men
1997, Jul: Compound Heterozygotes: May They Help to Understand the Pathophysiology of the Disease?
1997, May: Hepatic iron overload: diagnosis and quantification with MR imaging
1997, Feb: Genetic irony beyond haemochromatosis: clinical effects of HLA-H mutations
1997, Jan: The Relationship Between Iron Overload, Clinical Symptoms, and Age in 410 Patients With Genetic Hemochromatosis
1997, Jan: A new syndrome of liver iron overload with normal transferrin saturation
1997, Jan: Reversible cardiac dysfunction in hemochromatosis
1996, Dec: Clinical and biochemical abnormalities in people heterozygous for hemochromatosis
1996, Dec: Arthropathy as the Presenting Symptom in Hereditary Hemochromatosis.
1996, Dec: Clinical and biochemical abnormalities in people heterozygous for hemochromatosis
1996, Aug: Mutation Analysis in Hereditary Hemochromatosis
1996, Aug: A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis
1996, Apr: Long-term survival in patients with hereditary hemochromatosis xxx editorial
1996, Apr: Alcoholism in hereditary hemochromatosis revisited: prevalence and clinical consequences among homozygous siblings.
1996, Apr: Spontaneous multiple vertebral fractures revealed primary haemochromatosis
1996, Feb: Comparison of histological and biochemical hepatic iron indexes in the diagnosis of genetic haemochromatosis
1996, Feb: Practice guideline development task force of the College of American Pathologists. Hereditary hemochromatosis(4Mb)
1995, Jul: Primary liver cancer and survival in patients undergoing liver transplantation for hemochromatosis
1995, ???: Flawless phlebotomy: become a great collector
1994, Nov: Hemochromatosis: diagnosis and quantification of liver iron with gradient-echo MR imaging
1993, Sep: Idiopathic hemochromatosis: MR imaging findings in cirrhotic and precirrhotic patients
1993, Apr: Rate of iron reaccumulation following iron depletion in hereditary hemochromatosis. Implications for venesection therapy
1991, Apr: Clinical Presentation of Hemochromatosis: A Changing Scene
1984, ???: Primary Hemochromatosis: Anatomic and Physiologic C:haracteristics of the Cardiac Ventricles and Their Response to Phlebotomy
1983, Dec: Arthritis of hemochromatosis
1983, Dec: Arthritis of hemochromatosis. Clinical spectrum, relation to histocompatibility antigens, and effectiveness of early phlebotomy
1983, Okt: Cardiac hemochromatosis: beneficial effects of iron removal therapy. An echocardiographic study
1972, Jun: Joint and bone disorders and hypoparathyroidism in hemochromatosis
1972: ???: Ultra structural characteristics of the synovial membrane in idiopathic haemochromatosis
1972: ???: Synovial biopsy in haemochromatosis arthropathy
1972, ???: The spine in idiopathic haemochromatosis
1970, ???: 63 patients with iron overload.Clinical and radiological analysis of Arthropathy of haemochromatosis
1969, ???: Bone and joint changes in haemochromatosis
1959, Dec: A Familial Studv in Idiopathic Hemochromatosis
1953, ???: PHLEBOTOMY FOR HAEMOCHROMATOSIS EFFECT OF REMOVING 52 PINTS OF BLOOD IN SIXTEEN MONTHS
1963, ???: Hemochromatosis: Report of a Case Followed for Seven Years with Repeated Phlebotomies and Liver Biopsies 1999, Nov: Insulin resistance-associated hepatic iron overload
????. ???: Some Patients With Hereditary Hemochromatosis Do Not Require Chronic Therapeutic Phlebotomy